Table 4 Univariate and multivariate analyses of recurrence later than 5 years in patients with luminal tumors
From: Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer
Factors | Category | Later than 5 years | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
/total n | RR/CI | p | RR/CI | p | ||
T stage | ≤2 cm | 45/65 | 3.04/1.63–5.67 | <0.001 | 3.96/1.66–9.43 | 0.002 |
>2 cm | 60/141 | 1 | 1 | |||
N stage | Node− | 60/89 | 3.31/1.86–5.91 | <0.001 | 3.47/1.51–7.99 | 0.003 |
Node+ | 45/117 | 1 | 1 | |||
Grade | 1 | 15/23 | 1 | 1 | ||
2 | 53/115 | 0.46/0.18–1.16 | 0.099 | 0.15/0.04–0.62 | 0.008 | |
3 | 14/41 | 0.28/0.10–0.81 | 0.019 | 0.23/0.05–1.05 | 0.057 | |
ER titer | High ≥ 50 % | 72/139 | 8.06/1.78–36.57 | 0.007 | 10.4/1.88–57.5 | 0.007 |
Low < 50 % | 2/17 | 1 | 1 | |||
ER− or PR− | Yes | 101/176 | 8.75/2.93–26.15 | <0.001 | 2.95/0.12–74.6 | 0.511 |
No | 4/30 | 1 | 1 | |||
HER2 | Positive | 3/28 | 0.09/0.03–0.31 | <0.001 | 0.44/0.01–16.9 | 0.655 |
Negative | 102/178 | 1 | 1 | |||